WASHINGTON STATE REGISTER

WSR 08-09-045

PREPROPOSAL STATEMENT OF INQUIRY

DEPARTMENT OF

SOCIAL AND HEALTH SERVICES
(Health and Recovery Services Administration)

[ Filed April 10, 2008, 2:41 p.m. ]

аааааSubject of Possible Rule Making: Chapter 388-530 WAC, Outpatient drug program

аааааStatutes Authorizing the Agency to Adopt Rules on this Subject: RCW 74.08.090.

аааааReasons Why Rules on this Subject may be Needed and What They Might Accomplish: HRSA is updating the outpatient drug program rules to:

Х Correct typographical and grammatical errors.

Х Reinstate and clarify rules for vitamin and mineral coverage which were inadvertently omitted from the previous outpatient drug program WAC revision.

Х Reinstate and clarify rules for over-the-counter (OTC) coverage, which were inadvertently omitted from the previous outpatient drug program WAC revision.

Х Clarify (broaden) fluoride coverage, including age of children receiving fluoride.

Х Remove reference to the prior authorization requirements for the number of brand name drugs filled in a calendar month because the therapeutic consultation service has been eliminated.

Х Include combination drugs in the Washington preferred drug list that have been studied by the evidence-based practice center and have been reviewed by the P&T committee.

Х Clarify that some preferred drugs may require prior authorization or have specific limitations and still be subject to the therapeutic interchange program.

аааааProcess for Developing New Rule: DSHS welcomes the public to take part in developing the rules. Anyone interested should contact the staff person identified below. At a later date, DSHS will file a proposal with the office of the code reviser with a notice of proposed rule making. A copy of the proposal will be sent to everyone on the mailing list and to anyone who requests a copy.

аааааInterested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Jonell O. Blatt, P.O. Box 45504, phone (360) 725-1571, fax (360) 586-9727, TTY 1-800-848-5429, e-mail blattj@dshs.wa.gov.

April 10, 2008

Stephanie E. Schiller

Rules Coordinator

Х	Correct typographical and grammatical errors.
Х	Reinstate and clarify rules for vitamin and mineral coverage which were inadvertently omitted from the previous outpatient drug program WAC revision.
Х	Reinstate and clarify rules for over-the-counter (OTC) coverage, which were inadvertently omitted from the previous outpatient drug program WAC revision.
Х	Clarify (broaden) fluoride coverage, including age of children receiving fluoride.
Х	Remove reference to the prior authorization requirements for the number of brand name drugs filled in a calendar month because the therapeutic consultation service has been eliminated.
Х	Include combination drugs in the Washington preferred drug list that have been studied by the evidence-based practice center and have been reviewed by the P&T committee.
Х	Clarify that some preferred drugs may require prior authorization or have specific limitations and still be subject to the therapeutic interchange program.

й Washington State Code Reviser's Office